,
your personalized virtual assistant to find clinical trials. Go head, 
Pam G. Khosla, MD
Mount Sinai Hospital Medical CenterChicago, Illinois - 60608 (773-542-2000) |
- CLINICAL TRIALS 7
- CONDITIONS6
- INTERVENTIONS17
- SINCE2004
Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
June 2008 - December 2009
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
May 2009 - December 2012
Paclitaxel and Trastuzumab and/or Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery
December 2008 - June 2010
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
August 2008 - August 2013
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
July 2006 - April 2024
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB Stage II or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
June 2007 - July 2015
Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
January 2004 - January 2008
Breast Neoplasms
Lung Neoplasms
Prostatic Neoplasms
Neoplasm Metastasis
Head and Neck Neoplasms
Carcinoma, Non-Small-Cell Lung
Placebo
Zoledronic Acid
Paclitaxel
Carboplatin
Bevacizumab
Cisplatin
Docetaxel
Fluorouracil
Gemcitabine Hydrochloride
Cyclophosphamide
Pemetrexed Disodium
Doxorubicin Hydrochloride
Sunitinib Malate
Trastuzumab
Lapatinib Ditosylate
Vinorelbine Ditartrate
Antiandrogen Therapy
